Genmab | GEN - Kewajiban Lancar





Kewajiban Lancar Perubahan Tanggal
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Almirall EUR 323.65M 26.99M 2026-06
Amarin USD 164.2M 15.45M 2026-06
Amgen USD 25.5B 547M 2026-06
argenx SE USD 1.58B 254.81M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Bayer EUR 33.46B 875M 2026-03
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Demant DKK 7.42B 1.63B 2025-12
Exelixis USD 370.98M 34.67M 2026-03
Fresenius Medical Care EUR 6.73B 484.42M 2026-03
Genmab DKK 1.14B 38M 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
GN Store Nord DKK 4.81B 2.5B 2026-03
GRIFOLS EUR 2.24B 112M 2026-06
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Insmed USD 438.74M 77.74M 2026-06
Lakefront Biotherapeutics EUR 100.42M 52.44M 2026-03
Lonza CHF 3.57B 421M 2025-12
Merck EUR 9.35B 307M 2026-03
Novartis USD 31.75B 374M 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
UCB EUR 4.4B 470M 2025-12